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Abstract
Background Deterioration of left ventricular (LV) function
after myocardial infarction (MI) is a major cause of heart
failure. Myocardial perfusion performance may play an
important role in deterioration or improvement in LV func-
tion after MI. The aim of this study was to evaluate the
myocardial perfusion reserve (MPR) and stress perfusion in
deteriorating and non-deteriorating LV segments in patients
after MI by PET and MRI, respectively.
Methods Regional wall thickening of 352 segments in 22
patients was assessed at 4 and 24 months after MI by cardiac
MRI. PET was performed to evaluate MPR and adenosine
stress
13N-ammonia perfusion 24 months after MI. Segments
were divided into four groups according to deterioration or
improvement in wall thickening.
Results Normal functional segments at 4 months after MI
that remained stable had a significantly higher mean MPR and
mean stress perfusion PET value than deteriorated segments
(p<0.001). Furthermore, dysfunctional segments that im-
proved had a significantly higher mean stress perfusion PET
valuethandysfunctionalsegmentsthatremaineddysfunctional
(p<0.001).
Conclusion This study demonstrated the additional value of
myocardial perfusion assessment in relation to the functional
integrity ofthe injured myocardium. Segmental functional LV
improvement after MI was associated with better regional
myocardialperfusioncharacteristics.Furthermore,theamount
of wall thickening reduction was associated with regional
myocardial perfusion abnormalities in patients after MI.
Keywords Myocardialinfarction.Leftventricular
function.Myocardialperfusionimaging.CardiacMRI
Introduction
During recent decades, substantial improvements in the
treatment strategies in patients with myocardial infarction
(MI) have been achieved. Although this has greatly reduced
the rate of early mortality, MI-induced heart failure remains
a major cause of MI-associated morbidity and late mortality
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DOI 10.1007/s00259-012-2085-0[1]. After MI, spared myocardium should compensate for
tissue fibrosis due to MI. Two important determinants of
functional outcome are the amount of remaining myocardial
tissue and the myocardial perfusion dynamics of the spared
myocardium.
Myocardial perfusion performance depends on the condi-
tion of large (epicardial) and small (resistance) vessels. Defi-
cient myocardial perfusion is considered to play a key role in
pathophysiological processes involved in MI-induced heart
failure [2]. Inadequate angiogenesis, microvascular and car-
diomyocyte dysfunction, scar formation, and insufficient per-
fusion via the collateral coronary arteries will lead to
deterioration of heart function [3]. On the other hand, the
increase in myocardial perfusion caused by angiogenesis and
a sufficient number of collateral arteries may result in im-
provement in myocardial pump function. Angiogenesis can
be stimulated by means of gene therapy, e.g. VEGF [4, 5], or
experimentally by stem cell therapy [6].
PET-based myocardial perfusion imaging is used for
absolute quantification of myocardial perfusion (millilitres
per minute per gram) at the global and regional levels [5].
Due to accuracy of the myocardial perfusion imaging, myo-
cardial perfusion reserve (MPR, the ratio of near-maximal
myocardial blood flow to the baseline value) can be calcu-
lated. MPR and stress perfusion PET are used to assess
epicardial coronary arteries as well as microcirculatory func-
tion and the myocardial hemodynamic reserve [7, 8]. MRI is
a noninvasive imaging modality which provides clinicians
with accurate information of global and regional heart func-
tion with high spatial and temporal resolution [2, 6]. MR
images allow delineation of the myocardium, thus allowing
measurements of systolic wall thickening (WT). Combined
application of both PET and MRI will provide clinicians
with additional information on perfusion and function
parameters of the myocardium. Based on the relationship
between myocardial perfusion and myocardial function as
previously described in patients with idiopathic dilated car-
diomyopathy [9–11], we hypothesized that myocardial perfu-
sion is associated with changes in regional myocardial function
after MI. In this study, we therefore explored the relationship
between PET MPR, adenosine stress
13N-ammonia perfusion,
and changes in regional myocardial WT after MI as assessed
with MRI.
Materials and methods
Patients
Patients with MI admitted to the University Medical Center
Groningen (UMCG) were retrospectively included in this
study. They all underwent percutaneous coronary interven-
tion (PCI). Before starting the PCI procedure patients were
treated with aspirin, heparin and clopidogrel. After PCI
patients received a beta-blocker, aspirin, lipid-lowering thera-
py, and a renin-angiotensin-aldosterone system inhibitor com-
bined withclopidogrel. Patients participated in the HEBE trial
[6] and underwent a PET scan and were included by random
sampling for infarct size determination and detection of is-
chaemia. No differences in regional or global LV function
wereobserved between the HEBE treatment groups; therefore
we analysed our sample as a whole.
MRI
At 4 and 24 months after infarction cardiac MRI was per-
formed to assess left ventricular (LV) function. A 1.5-T MRI
scanner with a four-element phased array cardiac receiver
coil was used. Images were analysed using a dedicated
software package (QMass 7.2; Medis, Leiden, The Nether-
lands). Endocardial and epicardial borders in end-diastolic
and end-systolic images were outlined manually on short-
axis slices, covering the entire LV from base to apex
including the papillary muscles to the volume. For region-
al analysis the LV was divided into 16 different segments.
Segmental end-diastolic wall thickness (EDWT) and end-
systolic wall thickness (ESWT) were determined in milli-
metres. WT was calculated in each segment by subtracting
EDWT from ESWT. At each time-point a cut-off value of
3 mm was applied to consider segments as functional
versus dysfunctional [12]. All segments were divided into
four groups based on functionality at two time-points
(Table 1).
PET
The patients underwent a rest
13N-ammonia PET scan and
an adenosine-induced stress
13N-ammonia PET scan 24
months after MI. Patients refrained from caffeinated bever-
ages from 12 h prior to scanning. Imaging was performed
with the patient supine on an ECAT HR+ PET camera
(Siemens Medical Systems, Knoxville, TN). A transmission
scan for further attenuation correction was acquired for
5 min using an external ring source filled with
68Ge/
68Ga.
Accidental coincidence and dead time were automatically
Table 1 Myocardial segment groups in relation to WT at 4 and
24 months after MI. WT <3 mm was considered as dysfunctional and
WT ≥3 mm was considered as normal
Group Segments at 4 months Segments at 24 months
1 Normal Normal
2 Normal Dysfunctional
3 Dysfunctional Normal
4 Dysfunctional Dysfunctional
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2 min after injection of 400 MBq of
13N-ammonia and was
continued for 15 min. The same protocol was used 6 min
after intravenous injection of 0.14 mg/kg per minute aden-
osine to acquire stress myocardial perfusion images. A
parametric polar map was generated from the PET data.
These data were corrected for partial volume effects and
activity spillover from the blood pool. Regional (stress and
rest)myocardialbloodflowwascalculatedusinga17-segment
model, but reformatted in a 16 segment model corresponding
to the obtained MRI data. Segmental MPR was calculated by
dividing the adenosine stress
13N-ammonia PET result by the
rate pressure product normalized rest
13N-ammonia for each
segment.
Data analysis
The results are expressed as means±SD. The Kolmogorov-
Smirnov test was used to assess whether the MPR and WT
values were distributed normally. Due to a non-normal
distribution of WT values in the sample, the Kruskal-
Wallis test was used to compare the MPR and stress perfu-
sion PET values between different groups of WT. A paired
Student’s t-test was used to assess differences in WT be-
tween baseline and follow-up MRI. The significance level
was set at 0.05.
Results
We evaluated 352 segments in 22 patients. There were no
revascularization procedures between the first and second
time-points. Descriptive data on cardiovascular risk factors,
LV ejection fraction (LVEF), MPR, wall thickness and WT
at both time-points are shown in Table 2.
The first MRI scan was performed 4 months after MI. In
all 352 segments the mean values of EDWT, ESWTand WT
were 7.0±1.8, 10.4±2.9, and 3.5±2.1 mm, respectively. The
second MRI scan was performed 24 months after MI to
follow-up the patients’ myocardial function. The mean
values of EDWT, ESWT and WT in the second scan were
7.3±2.2mm (p<0.01),11.4±3.5mm (p<0.01) and 4.0±2.5 mm
(p<0.01), respectively.
The segments were divided according to the change in
WT functionality during the 20-month period between the
two MRI scans. At 24 months after MI, myocardial perfu-
sion as assessed by
13N-ammonia PET and MPR was cal-
culated. Table 3 shows the observed MPR, myocardial
perfusion values, and WT in the different groups. The group
1 pattern (normal segments at both time-points) was seen in
183 segments (WT 5.0±1.4 mm and 5.6±1.7 mm at 4 and
24 months, respectively) in 21 patients. The group 2 pattern
(normal segments at 4 months but WT below the normal
limit at 24 months) was seen in 28 segments (WT 3.8±0.7
mm and 1.8±0.9 mm at 4 and 24 months, respectively) in 16
patients. The group 3 pattern (dysfunctional segments at
4 months but WT improved at 24 months) was seen in 51
segments (WT 2.0±0.8 mm at 4 months and 4.5±1.3 mm at
24 months) in 19 patients. The group 4 pattern (dysfunctional
segments at both time-points) was seen in 90 segments (WT
1.2±1.1 mm and 1.2±1.7 mm at 4 and 24 months, respective-
ly) in 19 patients.
Table 2 Demographic and clinical characteristics of the 22 patients
Variable
Age (years, mean±SD) 61.7±6.8
Female (%) 13.6
Family history of cardiovascular diseases (%) 40.9
Smoker (%) 31.8
Diabetes mellitus (%) 4.5
Hypertension (%) 36.4
Hypercholesterolaemia (%) 27.3
LVEF (%, mean±SD)
4 months 38.6±7.5
24 months 41.2±8.9
MPR (mean±SD) 1.5±0.6
Stress
13N-ammonia (ml/min/100 g, mean±SD) 107.2±46.7
WT (mean±SD)
4 months (mm) 3.3±2.2
24 months (mm) 3.8±2.6
ΔWT (mm, mean±SD)
a 0.5±1.8
aDifference in WT between 4 and 24 months.
Table 3 Regional characteristics in relation to WT status. The data are presented as means±SD (for the definitions of the segment groups, see
Table 1)
Group No. of segments MPR Myocardial perfusion (ml/min/100 g) WT (mm)
Stress PET Rest PET 4 months 24 months
1 183 1.7±0.6 (0.1–3.7) 128.2±48.3 (5–347) 79.3±20.6 (34.3–140) 5.0±1.4 (3.0–10.5) 5.6±1.7 (2.7–11.4)
2 28 1.2±0.5 (0.1–2.3) 82. 7±30.2 (9–157) 71.2±16.9 (31.4–105.3) 3.8±0.7 (3.0–5.7) 1.8±0.9 (−0.8–2.9)
3 51 1.5±0.6 (0.1–3.4) 100.7±36.2 (6–170) 70.8±21.5 (33.8–118.1) 2.0±0.8 (0.3–2.9) 4.5±1.3 (3.0–7.7)
4 90 1.3±0.5 (0.2–3.5) 83.2±34.7 (20–198) 65.8±21.4 (26.2–137.1) 1.2±1.1 (−1.5–2.8) 1.2±1.7 (−2.4–2.9)
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and 1.3±0.5 in groups 1–4, respectively. Overall, the mean
MPR in the 352 segments was 1.5±0.6 (Table 3). The mean
stress perfusion PET values in groups 1–4 were 128.2±48.3,
82.7±30.2, 100.7±36.2 and 83.2±34.7 ml/min/100 g, respec-
tively. Groups 1 and 2 (both normal functional segments at
4 months) showed significantly lower mean MPR and stress
perfusion PET values in the deteriorated segments at
24 months (perfusion 128.2±48.3 vs. 82. 7±30.2 ml/min/
100 g; p<0.001) than the group with remaining normal
functional segments. Groups 3 and 4 (both dysfunctional seg-
ments at 4 months) showed higher mean MPR and stress
perfusion PET values in the functionally improved segments
at 24 months (perfusion 100.7±36.2 vs. 83.2±34.7 mL/min/
100 g, p00.001; MPR, borderline significance, p00.05) than
the group with remaining dysfunctional segments (Table 3).
Discussion
In the present study we evaluated the relationship between
changes in regional myocardial WT between 4 and
24 months after MI and PET myocardial perfusion. The
main finding of this study was the association between
segmental LV function deterioration and a lower stress
perfusion as well as perfusion reserve.
Congestive heart failure is the leading cause of MI-
associated mortality and mortality [1]. The influence of myo-
cardial perfusion and microvascular condition on myocardial
contractility has been evaluated in several studies in patients
with nonischaemic heart failure [11, 13, 14]. Myocardial
remodelling in response to functional loss after an MI greatly
depends on sufficient perfusion and oxygen supply. Reduced
MPR and stress perfusion PET values as were found in the
deteriorated segments may imply insufficient oxygen supply as
a cause of deterioration. Improvement in segmental function
may on the one hand relate to recovery after myocardial stun-
ningandontheotherhandreflectcompensationbythehealthy/
spared myocardium for the loss of infarcted tissue. Deteriora-
tion of previously functional segments may reflect the inability
of the tissue to adapt to the increase in metabolism needed for
this compensation. The present study, however, could not
differentiate between cause and consequence. The results of
this study may merely reflect the difference in myocardial
perfusion between normal and remodelled myocardium.
The prognostic role of regional and global MPR in patients
with hypertrophic cardiomyopathy [13, 15], idiopathic LV
dysfunction [16] andischaemic heart disease[17, 18]h a sb e e n
shown in previous studies. The present study did not evaluate
the prognostic value of myocardialperfusionmeasurementbut
focused on the possible mechanism of deteriorating LV func-
tion after MI. These data do, however, further elaborate on
MPR and stress perfusion PET values in a well-characterized
group of patients with a previous MI. The observation that
contractile deterioration is directly associated with reduced
perfusion dynamics further underlines the microcirculation as
an important diagnostic and possible therapeutic target in
patients following MI. Death of cardiomyocytes is followed
by inflammation, proliferating myofibroblasts and migration
of endothelial cells into the infarct zone replacing dead tissue
with granulation tissue [19]. Concomitantly, vβ3 integrins are
upregulated in the infarct region [20]. It is well recognized that
the expression of the b3 integrins contributes to angiogenesis
intheperi-infarct zoneasapartof theremodellingprocess,and
occurs early, peaking about 7 days after MI. It has been
postulated that the extent of neovascularization determines
the functional integrity of the (spared) myocardium [2].
Using serial MRI measurements after MI functional seg-
mental LV changes can be identified. At present the clinical
importance of such changes remains to be determined. PET
perfusion imaging may be of additional clinical assistance.
It would be worth evaluating the usefulness of prospective
PET perfusion assessment in the prediction of LV deterio-
ration/heart failure in later stages. If such an approach was
proved to be of value, it could be used for guiding person-
alized therapy in patients with heart disease.
A limitation of this study was the relatively low number
of included patients, but the number of analysed LV seg-
ments was large. Also data on long-term outcomes were not
available in this study, but need to be collected in future
studies. These data are of importance for determining if
stress perfusion and MPR PET are still linked over the long
term with LV the contractility pattern after MI.
In conclusion, the combination of PET and MRI is a pow-
erful tool for evaluating the relationship between myocardial
perfusion and contractility changes after MI at a regional level.
The observation that functional deterioration is accompanied
by reduced stressperfusion as well as perfusionreserve further
emphasizes the relationship between sufficient oxygen supply
and cardiac remodelling after MI. Future research should
establish whether prognostic evaluation of perfusion reserve
could identify patients at risk of developing heart failure.
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